Axonal Degeneration Prone Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Axonal degeneration-prone neurons are neuronal populations susceptible to dying-back (dying-back) axonopathy, where axonal dysfunction and degeneration precede cell body death. This pattern is characteristic of many neurodegenerative diseases.
- Neurofilaments (NFL, NFM, NFH): Structural proteins
- Tau: Axonal microtubule stabilization
- MAP1A/1B: Microtubule-associated proteins
- Spectrin: Membrane skeleton
- Ankyrin G: Axon initial segment
- APP accumulation: Axonal transport defect
- Amyloid precursor protein: Axonal injury marker
- SMI-32: Non-phosphorylated neurofilament
- SMI-31: Phosphorylated neurofilament
- Motor neuron axons
- Longest axons most vulnerable
- Distal axon degeneration
- NMJ denervation
- Sensory and motor axons
- Primary axonal disorder
- Myelin sheath abnormalities
- Distal axon terminals: First affected
- Intermediate segments: Progressive loss
- Proximal segments: Later involvement
- Cell body: Survives initially
- Axonal transport defects: Kinesin/dynein dysfunction
- Mitochondrial deficiency: Energy deficit
- Cytoskeletal breakdown: Neurofilament accumulation
- Calcium dysregulation: Local calcium overload
- Protein aggregation: Transport obstruction
- ATP depletion: Na+/K+ pump failure
- Calcium dysregulation: Calpain activation
- Proteolysis: Casepase activation
- Axonal transport enhancers: 3,4-Diaminopyridine
- Neurotrophic factors: BDNF, CNTF
- Mitochondrial protectors: CoQ10, creatine
- Cytoskeletal stabilizers: Microtubule-stabilizing agents
- NF-L gene therapy: Structural support
- Kinesin enhancement: Transport improvement
- SARM1 inhibitors: Axonal degeneration blockade
- NFL in serum/CSF (axonal damage)
- Neuroimaging of white matter
- Postmortem axonal counts
The study of Axonal Degeneration Prone Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Adalbert, R., & Coleman, M.P. (2013). Review: Axon pathology in age-related neurodegenerative disorders. Neuropathology and Applied Neurobiology, 39(2), 90-108.
- Wang, J.T., et al. (2012). Dying back: Neurodegeneration. Nature Reviews Neuroscience, 13(8), 563.
- Conforti, L., et al. (2014). Axonal degeneration: From mechanisms to therapies. Neuron, 82(1), 12-15.
- Cavanagh, J.B. (1984). The rate of dissolution of axons. Acta Neuropathologica, 64(2), 85-91.
- Saxena, S., & Caroni, P. (2011). Selective vulnerability of specific neuronal compartments. Progress in Molecular Biology and Translational Science, 103, 211-239.